Needle in a haystack

Illustration of glycoproteins present on the highly glycosylated cell surface. These proteins, often specific to diseases, can be shed or secreted into the blood stream and so are ideal targets for biomarker discovery. Credit: courtesy of Ralph Schiess and Reto Ossola, Swiss Federal Institute of Technology" />Illustration of glycoproteins present on the highly glycosylated cell surface. These

Written byJeffrey M. Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researcher:
Ruedi Aebersold, professor of molecular systems biology, Swiss Federal Institute of Technology, Zurich

Project:
Cancer biomarker discovery in serum

Problem:
If most proteins are glycosylated, most peptides are not. Thus, a whole-cell or whole-serum protein extract can overwhelm a mass spectrometer. Aebersold needed a way to focus only on glycosylated fragments.

Solution:
Aebersold enriched his samples with a method called solid-phase extraction of N-linked glycopeptides ( Nat Protocols, 2:334-9, 2007). A protein extract is digested to peptides, and treated with sodium periodate to oxidize the sugars to aldehydes. These activated sugars are then chemically coupled to hydrazide beads, while unmodified peptides are washed away. Finally, the peptides are cleaved from the resin using protein N-glycanase (PNGase)-F, leaving the glycan groups, and are sequenced via tandem mass spec.

Whereas a typical protein may yield 100 or so tryptic peptides, "Typically, a glycoprotein treated in this way will produce three to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies